Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Cadila Healthcare Limited
483
•Cadila Healthcare Limited•March 1, 2017

Cadila Healthcare Limited – FDA 483, Mar 1, 2017

Record Details

FDA investigators conducted an inspection of Cadila Healthcare Ltd. in Baddi, India, from March 1 to March 17, 2017. The inspection revealed several significant deficiencies in the facility's quality control and manufacturing processes, leading to the issuance of a Form 483 with multiple observations.

One key observation noted that the quality control unit lacked adequate procedures to ensure the integrity and accuracy of data. Specifically, the firm's audit trail review for chromatographic data was found to be insufficient, with no documented evidence of review for data generated by the Empower 3 software. This raises concerns about data integrity and the reliability of analytical results used for batch release.

Another critical finding involved the firm's handling of out-of-specification (OOS) results. The investigation into an OOS result for related substances in a stability sample of Esomeprazole Magnesium Delayed-Release Capsules was deemed inadequate. The firm failed to identify a root cause for the OOS result, and the retesting performed was not justified, leading to an invalidation of the initial OOS result without proper scientific rationale. This indicates a weakness in their OOS investigation procedures and a potential risk of releasing non-conforming products.

Furthermore, the inspection revealed that the firm's procedures for cleaning and maintenance of equipment were deficient. Specifically, the cleaning validation for certain manufacturing equipment was not adequately established or followed, potentially leading to cross-contamination of products.

These observations indicate a

Company
Cadila Healthcare Limited
Inspection date
March 1, 2017
Office
Center for Drug Evaluation and Research
People
  • Nicole E. Knowlton (Investigator )
  • E Moore (Investigator)
View Company Profile

ID · 21e00164-ae0d-4370-97c3-202339e6ad67

Violation Codes1
21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Cadila Healthcare Limited
  • WARNING_LETTER - 2019-05-03May 3, 2019
  • WARNING_LETTER - 2014-12-06December 6, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cadila Healthcare Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.